Orchestra BioMed Holdings (OBIO) Cash & Equivalents (2022 - 2025)
Historic Cash & Equivalents for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $74.0 million.
- Orchestra BioMed Holdings' Cash & Equivalents rose 3556.42% to $74.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.0 million, marking a year-over-year increase of 3556.42%. This contributed to the annual value of $56.8 million for FY2024, which is 3288.39% down from last year.
- Per Orchestra BioMed Holdings' latest filing, its Cash & Equivalents stood at $74.0 million for Q3 2025, which was up 3556.42% from $24.3 million recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Cash & Equivalents registered a high of $126.6 million during Q1 2023, and its lowest value of $735217.0 during Q3 2022.
- Moreover, its 4-year median value for Cash & Equivalents was $56.8 million (2024), whereas its average is $58.4 million.
- In the last 5 years, Orchestra BioMed Holdings' Cash & Equivalents soared by 1396251.49% in 2023 and then crashed by 5490.16% in 2025.
- Orchestra BioMed Holdings' Cash & Equivalents (Quarter) stood at $82.6 million in 2022, then rose by 2.5% to $84.6 million in 2023, then plummeted by 32.88% to $56.8 million in 2024, then surged by 30.2% to $74.0 million in 2025.
- Its last three reported values are $74.0 million in Q3 2025, $24.3 million for Q2 2025, and $40.2 million during Q1 2025.